Video

ecancer's extensive video archive features interviews, panel discussions and conference coverage on almost every topic in oncology.

MS-553 shows promise in treating chronic lymphocytic leukaemia

Prof Jennifer Woyach - The Ohio State University, Columbus, USA
MS-553 shows promise in treating chronic lymphocytic leukaemia ( Prof Jennifer Woyach - The Ohio State University, Columbus, USA )
15 Jan 2026

Enhancing cancer care in Africa: Patient perspectives and quality improvement

Dr Verna Vanderpuye - Korle-Bu Teaching Hospital, Accra, Ghana
Enhancing cancer care in Africa: Patient perspectives and quality improvement ( Dr Verna Vanderpuye - Korle-Bu Teaching Hospital, Accra, Ghana )
13 Jan 2026

Liso-cel in r/r follicular lymphoma shows durable 3-year responses and favourable long-term safety

Dr Sairah Ahmed - MD Anderson Cancer Network, Houston, USA
Liso-cel in r/r follicular lymphoma shows durable 3-year responses and favourable long-term safety ( Dr Sairah Ahmed - MD Anderson Cancer Network, Houston, USA )
8 Jan 2026

TKI chemotherapy and ponatinib improve survival outcomes in blast phase CML

Dr Akriti Jain - Cleveland Clinic, Cleveland, USA
TKI chemotherapy and ponatinib improve survival outcomes in blast phase CML ( Dr Akriti Jain - Cleveland Clinic, Cleveland, USA )
8 Jan 2026

Consolidation treatment delays do not compromise survival in MRD-negative adult ALL

Prof Bhavana Bhatnagar - WVU Medicine Wheeling Hospital, Wheeling, USA
Consolidation treatment delays do not compromise survival in MRD-negative adult ALL ( Prof Bhavana Bhatnagar - WVU Medicine Wheeling Hospital, Wheeling, USA )
7 Jan 2026

Multimodal AI model augments Oncotype DX in predicting distant recurrence in HR+/HER2 node negative BC

Dr Joseph Sparano - Icahn School of Medicine at Mount Sinai, New York, USA
Multimodal AI model augments Oncotype DX in predicting distant recurrence in HR+/HER2 node negative BC ( Dr Joseph Sparano - Icahn School of Medicine at Mount Sinai, New York, USA )
22 Dec 2025

Higher tumour-infiltrating lymphocytes predict better pathologic response in HER2-positive breast cancer

Prof Sunil Badve - Emory University, Atlanta, USA
Higher tumour-infiltrating lymphocytes predict better pathologic response in HER2-positive breast cancer ( Prof Sunil Badve - Emory University, Atlanta, USA )
22 Dec 2025

Dasatinib, prednisone, and blinatumomab combination shows promising outcomes in elderly patients with Ph+ ALL

Dr Anjali Advani - Cleveland Clinic, Cleveland, USA
Dasatinib, prednisone, and blinatumomab combination shows promising outcomes in elderly patients with Ph+ ALL ( Dr Anjali Advani - Cleveland Clinic, Cleveland, USA )
19 Dec 2025

Blinatumomab plus chemotherapy shows manageable toxicity in adults with Ph- B-ALL

Dr Anjali Advani - Cleveland Clinic, Cleveland, USA
Blinatumomab plus chemotherapy shows manageable toxicity in adults with Ph- B-ALL ( Dr Anjali Advani - Cleveland Clinic, Cleveland, USA )
19 Dec 2025

Tucatinib added to trastuzumab and pertuzumab improves PFS in first-line HER2-positive metastatic breast cancer

Dr Erika Hamilton - Sarah Cannon Research Institute, Nashville, USA
Tucatinib added to trastuzumab and pertuzumab improves PFS in first-line HER2-positive metastatic breast cancer ( Dr Erika Hamilton - Sarah Cannon Research Institute, Nashville, USA )
19 Dec 2025

Sacituzumab govitecan improves quality of life in untreated advanced TNBC

Dr Kevin Punie - Ziekenhuis aan de Stroom, Antwerp, Belgium
Sacituzumab govitecan improves quality of life in untreated advanced TNBC ( Dr Kevin Punie - Ziekenhuis aan de Stroom, Antwerp, Belgium )
18 Dec 2025

Comment: Pirtobrutinib improves PFS in treatment-naïve CLL/SLL compared to bendamustine/rituximab

Dr Tycel Phillips - City of Hope National Medical Center, Duarte, USA
Comment: Pirtobrutinib improves PFS in treatment-naïve CLL/SLL compared to bendamustine/rituximab ( Dr Tycel Phillips - City of Hope National Medical Center, Duarte, USA )
18 Dec 2025